Fuller & Thaler Asset Management, Inc. Enzo Biochem Inc Transaction History

Fuller & Thaler Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.84 - $2.66 $5,750 - $8,312	3,125 Added 0.32%	985,660 $1.81 Million
Q1 2023 May 15, 2023	SELL	$1.0 - $2.51 $750 - $1,882	-750 Reduced 0.08%	982,535 $2.39 Million
Q4 2022 Feb 13, 2023	BUY	$1.16 - $2.42 $14,238 - $29,705	12,275 Added 1.26%	983,285 $1.41 Million
Q3 2022 Nov 14, 2022	BUY	$2.1 - $2.73 $28,402 - $36,923	13,525 Added 1.41%	971,010 $2.17 Million
Q2 2022 Aug 12, 2022	BUY	$2.0 - $3.0 $12,500 - $18,750	6,250 Added 0.66%	957,485 $1.98 Million
Q1 2022 May 13, 2022	BUY	$2.9 - $3.47 $14,355 - $17,176	4,950 Added 0.52%	951,235 $2.76 Million
Q4 2021 Feb 09, 2022	BUY	$3.17 - $4.09 $14,344 - $18,507	4,525 Added 0.48%	946,285 $3.04 Million
Q3 2021 Nov 10, 2021	SELL	$3.01 - $3.77 $13,319 - $16,682	-4,425 Reduced 0.47%	941,760 $3.33 Million
Q2 2021 Aug 13, 2021	BUY	$2.86 - $3.61 $2.71 Million - $3.42 Million	946,185 New	946,185 $3 Million

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.